Stephen V. Faraone, PhD

Sleep-Associated Adverse Events During Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder in Youth: A Meta-Analysis

Purpose: Sleep disturbances are associated with attention-deficit/hyperactivity disorder (ADHD) and methylphenidate (MPH) treatment. We assessed whether sleep-related adverse event (AE) r...

Michelle Po , PhD;

Marina Komolova , PhD;

Samuele Cortese , MD;

Stephen V. Faraone , PhD;

11/22/2019

Non-Medical Use of Prescription Stimulants Reported by Adults Entering Substance Abuse Treatment

This poster was presented at the 31st annual Psych Congress, held Oct. 25-28, 2018, in Orlando, Florida.

Jody Green , PhD;

Natasha Oyedele , MPH, MSc;

Stephen Butler , PhD;

Stephen V. Faraone , PhD;

Jeffrey Newcorn , MD;

03/01/2019

Improvements in At-Home Functional Impairment With DR/ER-MPH in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Post Hoc Analysis of BSFQ and PREMB-R by Norm-Referenced Cut-Offs

Background: Age-adjusted cut-offs for two scales of ADHD-related at-home functional impairment, the Before School Functioning Questionnaire (BSFQ) and the Parent Rating of Evening and Mor...

Steven Pliszka , MD;

F. Randy Sallee , MD, PhD;

Jeffrey Newcorn , MD;

Stephen V. Faraone , PhD;

Norberto DeSousa , MA;

Timothy Wilens , MD;

Bev Incledon , PhD;

03/01/2019

Clinically Meaningful Improvements With DR/ER-MPH in At-Home Functional Impairment During the Early Morning and Late Afternoon/Evening in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Background: In a pivotal, randomized, double-blind, placebo-controlled, phase 3 trial of children (6–12y) with ADHD (NCT02520388), treatment with HLD200, an evening-dosed, delayed-release...

Norberto DeSousa , MA;

Bev Incledon , PhD;

F. Randy Sallee , MD, PhD;

Stephen V. Faraone , PhD;

Timothy Wilens , MD;

Paul Hammerness , MD;

Steven Pliszka , MD;

Jeffrey Newcorn , MD;

03/01/2019

Adolescent Non-Medical Use of Prescription Stimulants: Prevalence, Route and Drug Acquisition

Prescription stimulants often prescribed for attention deficit hyperactivity disorder have been highlighted by regulatory agencies and others as emerging drugs of misuse/abuse. Non-medica...

Stephen V. Faraone , PhD;

Jeffrey Newcorn , MD;

Jody Green , PhD;

Natasha Oyedele , MPH, MSc;

Stephen Butler , PhD;

03/01/2019

College Students Involved in Greek Life are at Higher Risk for Nonmedical Use of Prescription Stimulants, Particularly via Non-oral Routes

College students are an at-risk population for prescription stimulant nonmedical use (NMU; use for any reason or in any way other than prescribed, including misuse/abuse). An online surve...

Stephen Butler , PhD;

Stephen V. Faraone , PhD;

Jody Green , PhD;

10/08/2020

Attention Deficit Hyperactivity Disorder (ADHD), College Students, and Nonmedical Use of Prescription Stimulants via High Risk Routes of Administration

Regulatory agencies and others have highlighted prescription ADHD stimulant medications as emerging drugs of misuse/abuse. College students, an especially high-risk group for stimulant mi...

Stephen V. Faraone , PhD;

Jody Green , PhD;

Stephen Butler , PhD;

10/08/2020

A randomized, placebo-controlled trial to evaluate the efficacy and safety of AR19 (amphetamine sulfate) in adults with attention-deficit/hyperactivity disorder

Background: AR19 is a pellets-in-capsule, immediate-release amphetamine sulfate investigational formulation with physical and chemical barriers designed to resist manipulation to deter sn...

Steven Caras , MD, PhD;

Anthony Rostain , MD;

Stephen V. Faraone , PhD;

10/08/2020